Pain Mechanisms and Neuroinflammation in OA

Plenary Session 5

Date: Saturday, April 26, 2025
Time: 10:45 AM to 12:15 PM

Moderators:	Anne-Marie Malfait Kai Fu
10:45 AM - 11:25 AM	Neuroinflammation & Pain: Beyond Immune Cells Franziska Denk
11:25 AM - 11:35 AM	085: LEVI-04, A NOVEL NEUROTROPHIN-3 INHIBITOR, SUBSTANTIALLY IMPROVES PAIN AND FUNCTION IN PEOPLE WITH KNEE OSTEOARTHRITIS: A RANDOMISED CONTROLLED PHASE II TRIAL. Philip G. Conaghan
11:35 AM - 11:45 AM	086: PROTON-SENSING GPR68 REGULATES JOINT ACIDOSIS AND MODULATES INFLAMMATION AND CATABOLISM IN OSTEOARTHRITIS Colette Hyde
11:45 AM - 11:55 AM	087: MAPPING THE SYNOVIAL INNERVATION OF THE HUMAN KNEE JOINT Alia Obeidat
11:55 AM - 12:05 PM	088: THE CD13/B1R AXIS MEDIATES SYNOVITIS IN PTOA Easton Farrell
12:05 AM - 12:07 PM	089: ASSOCIATION OF CENTRAL PAIN SENSITIZATION WITH PREFRONTAL CORTEX ACTIVATION DURING SINGLE- AND DUAL-TASK WALKING IN KNEE OSTEOARTHRITIS Soyoung Lee
12:07 PM - 12:09 PM	090: THE RELATIONS OF ANALGESIC ANTIDEPRESSANTS USE TO TOTAL JOINT ARTHROPLASTY AMONG OSTEOARTHRITIS PATIENTS COMPARED TO SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN A LARGE PROSPECTIVE COHORT Zhiqiang Wang
12:09 PM - 12:11 PM	091: COGNITIVE BIAS AND HEURISTICS ARE ASSOCIATED WITH IMPROVEMENT IN KNEE PAIN IN PATIENTS WITH KNEE OSTEOARTHRITIS TREATED WITH OPEN LABEL PLACEBO Tommy Kok Kok Annfeldt
12:11 PM - 12:13 PM	092: PHASE I/II CLINICAL TRIAL OF ALLOCETRATM CELL THERAPY FOR KNEE OSTEOARTHRITIS: INITIAL EVIDENCE OF RESPONSE TO INFLAMMATION MODULATION Einat Galamidi
12:13 PM - 12:15 PM	Q & A